Patents Assigned to CJ BIOSCIENCE, INC.
  • Patent number: 11857614
    Abstract: The invention provides compositions comprising flagellin polypeptides from bacterial strains and the use of such compositions in the treatment of disease.
    Type: Grant
    Filed: September 18, 2020
    Date of Patent: January 2, 2024
    Assignee: CJ BIOSCIENCE, INC.
    Inventors: Imke Elisabeth Mulder, Emma Raftis, Emma Elizabeth Clare Hennessy, Delphine Louise Claudette Laute-Caly, Philip Cowie
  • Publication number: 20230330159
    Abstract: The present invention relates to a Faecalibacterium sp. microorganism and a composition for diagnosis or treatment of bowel diseases, comprising same.
    Type: Application
    Filed: September 27, 2021
    Publication date: October 19, 2023
    Applicant: CJ Bioscience, Inc.
    Inventors: Sang Hi HONG, Je Hee LEE, Kyoung-Jin CHOE, Seok-Hwan YOON, Hyeonseok OH, Hyun KIM, Dahye KIM
  • Patent number: 11779613
    Abstract: The invention provides compositions comprising bacterial strains for treating and preventing neurodegenerative disorders.
    Type: Grant
    Filed: April 2, 2021
    Date of Patent: October 10, 2023
    Assignee: CJ BIOSCIENCE, INC.
    Inventors: Imke Elisabeth Mulder, Samantha Yuille, Anna Ettorre, Suaad Ahmed, Parthena Fotiadou, Joseph Roby Iringan Urcia, Helene Savignac
  • Patent number: 11723933
    Abstract: The present invention provides a strain of Bacteroides thetaiotaomicron and derivatives thereof, and the use of said strain or derivatives in treating inflammatory, autoimmune and allergic disorders. The invention also provides pharmaceutical compositions, nutritional supplements, feedstuffs, food products, dietary supplements, and food additives comprising said strain or derivatives.
    Type: Grant
    Filed: January 15, 2019
    Date of Patent: August 15, 2023
    Assignee: CJ BIOSCIENCE, INC.
    Inventors: Angela Margaret Patterson, George Grant, Imke Mulder
  • Publication number: 20230223146
    Abstract: The present disclosure proposes an apparatus for determining an intestinal microbiome index. The apparatus according to the present disclosure may: obtain test information about a biological sample of a subject from a test apparatus; determine, based on the test information, first information about the similarity of intestinal microflora, second information about a proportion of harmful intestinal microflora, third information about a proportion of beneficial intestinal microflora, and/or fourth information about the diversity of intestinal microflora; and determine an intestinal microbiome index indicating a state of intestinal microbiome of the subject based on the determined information.
    Type: Application
    Filed: June 16, 2021
    Publication date: July 13, 2023
    Applicant: CJ BIOSCIENCE, INC.
    Inventors: Ui Gi MIN, Hyeon Seok OH, Nam II KIM, Jeong Min LIM, Eun Hye KIM